These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

478 related items for PubMed ID: 20303156

  • 1. Overcoming the barriers to HPV vaccination in high-risk populations in the US.
    Downs LS, Scarinci I, Einstein MH, Collins Y, Flowers L.
    Gynecol Oncol; 2010 Jun; 117(3):486-90. PubMed ID: 20303156
    [Abstract] [Full Text] [Related]

  • 2. What is the role of HPV typing in the United States now and in the next five years in a vaccinated population?
    Huh W, Einstein MH, Herzog TJ, Franco EL.
    Gynecol Oncol; 2010 Jun; 117(3):481-5. PubMed ID: 20417957
    [Abstract] [Full Text] [Related]

  • 3. Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: a cross-sectional study.
    Jaspers L, Budiningsih S, Wolterbeek R, Henderson FC, Peters AA.
    Vaccine; 2011 Oct 13; 29(44):7785-93. PubMed ID: 21821079
    [Abstract] [Full Text] [Related]

  • 4. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M, Jasani B, Fiander A.
    Vaccine; 2007 Apr 20; 25(16):3007-13. PubMed ID: 17292517
    [Abstract] [Full Text] [Related]

  • 5. Knowledge and attitudes of adult peruvian women vis-à-vis Human Papillomavirus (HPV), cervical cancer, and the HPV vaccine.
    Lee FH, Paz-Soldan VA, Carcamo C, Garcia PJ.
    J Low Genit Tract Dis; 2010 Apr 20; 14(2):113-7. PubMed ID: 20354419
    [Abstract] [Full Text] [Related]

  • 6. Programmatic issues in the implementation of an HPV vaccination program to prevent cervical cancer.
    Ault K, Reisinger K.
    Int J Infect Dis; 2007 Nov 20; 11 Suppl 2():S26-8. PubMed ID: 18162242
    [Abstract] [Full Text] [Related]

  • 7. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM, Cuzick J, Domingo EJ, Goldie SJ, Kim YT, Konno R, Parkin DM, Qiao YL, Sankaranarayanan R, Stern PL, Tay SK, Bosch FX.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [Abstract] [Full Text] [Related]

  • 8. [Vaccination against human papillomavirus for the prevention of cervical cancer].
    Quint WG, ter Harmsel WA, van Doorn LJ.
    Ned Tijdschr Geneeskd; 2006 Jun 24; 150(25):1380-4. PubMed ID: 16841585
    [Abstract] [Full Text] [Related]

  • 9. Public health issues related to HPV vaccination.
    Hershey JH, Velez LF.
    J Public Health Manag Pract; 2009 Jun 24; 15(5):384-92. PubMed ID: 19704306
    [Abstract] [Full Text] [Related]

  • 10. Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal.
    Sankaranarayanan R, Bhatla N, Gravitt PE, Basu P, Esmy PO, Ashrafunnessa KS, Ariyaratne Y, Shah A, Nene BM.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M43-52. PubMed ID: 18945413
    [Abstract] [Full Text] [Related]

  • 11. Singaporean men's knowledge of cervical cancer and human papillomavirus (HPV) and their attitudes towards HPV vaccination.
    Pitts M, Smith A, Croy S, Lyons A, Ryall R, Garland S, Wong ML, Hseon TE.
    Vaccine; 2009 May 14; 27(22):2989-93. PubMed ID: 19428910
    [Abstract] [Full Text] [Related]

  • 12. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
    Schneider A, Schwarz TF, Hammerschmidt T, Siebert U.
    Med Klin (Munich); 2007 Jul 15; 102(7):515-23. PubMed ID: 17634869
    [Abstract] [Full Text] [Related]

  • 13. [Cervical cancer prevention: the impact of HPV vaccination].
    Monsonégo J.
    Gynecol Obstet Fertil; 2006 Mar 15; 34(3):189-201. PubMed ID: 16529969
    [Abstract] [Full Text] [Related]

  • 14. Epidemiology of human papillomavirus infection and cervical cancer and future perspectives in Hong Kong, Singapore and Taiwan.
    Tay SK, Ngan HY, Chu TY, Cheung AN, Tay EH.
    Vaccine; 2008 Aug 19; 26 Suppl 12():M60-70. PubMed ID: 18945415
    [Abstract] [Full Text] [Related]

  • 15. A qualitative analysis of South African women's knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health.
    Francis SA, Battle-Fisher M, Liverpool J, Hipple L, Mosavel M, Soogun S, Mofammere N.
    Vaccine; 2011 Nov 03; 29(47):8760-5. PubMed ID: 21855591
    [Abstract] [Full Text] [Related]

  • 16. Initial lessons learned in HPV vaccination.
    Herzog TJ, Huh WK, Downs LS, Smith JS, Monk BJ.
    Gynecol Oncol; 2008 May 03; 109(2 Suppl):S4-11. PubMed ID: 18482557
    [Abstract] [Full Text] [Related]

  • 17. Human papillomavirus vaccine acceptability among young adult men.
    Gerend MA, Barley J.
    Sex Transm Dis; 2009 Jan 03; 36(1):58-62. PubMed ID: 18830138
    [Abstract] [Full Text] [Related]

  • 18. Epidemiology of HPV 16 and cervical cancer in Finland and the potential impact of vaccination: mathematical modelling analyses.
    Barnabas RV, Laukkanen P, Koskela P, Kontula O, Lehtinen M, Garnett GP.
    PLoS Med; 2006 May 03; 3(5):e138. PubMed ID: 16573364
    [Abstract] [Full Text] [Related]

  • 19. Preventing cervical cancer through human papillomavirus vaccination: perspective from focus groups.
    Wong LP.
    J Low Genit Tract Dis; 2009 Apr 03; 13(2):85-93. PubMed ID: 19387128
    [Abstract] [Full Text] [Related]

  • 20. Difficulties in the prevention of cervical cancer: adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in Hungary.
    Marek E, Dergez T, Kricskovics A, Kovacs K, Rebek-Nagy G, Gocze K, Kiss I, Ember I, Gocze P.
    Vaccine; 2011 Jul 18; 29(32):5122-9. PubMed ID: 21624417
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.